High-Priority Research in Tobacco Regulatory Science (Clinical Trial Optional)
Past Federal grant forecast Posted
- Opportunity number
- RFA-OD-26-006
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications expected due
- Award size
- Up to $500,000
Opportunity facts
- Expected posting
- Assistance listings
- Funding instrument
- Grant
- Category
-
- Health
- Eligible applicants
-
- Special District Governments
- Small Businesses
- Tribal Governments (Federally Recognized)
- 501(c)(3) Nonprofits
- City/Township Governments
- Higher Education Inst. (Public)
- Tribal Organizations (Not Federally Recognized)
- Independent School Districts
- Non-501(c)(3) Nonprofits
- County Governments
- State Governments
- Higher Education Inst. (Private)
- For Profit Organizations
- Other
- Public or Indian Housing Auth.
- Points of contact
-
- Erik Rodriquez trsp@nih.gov (301) 827-2830
Opportunity details come from Grants.gov. Updated .
About this opportunity
The National Institutes of Health, in partnership with the FDA Center for Tobacco Products, is forecasting a Notice of Funding Opportunity to solicit grant applications for High-Priority Research Projects in Tobacco Regulatory Science (Clinical Trial Optional); no application deadline is specified in this forecast announcement.
Eligible applicants include special district governments, small businesses, federally recognized and non-federally recognized tribal governments and organizations, 501(c)(3) and non-501(c)(3) nonprofits, city/township and county governments, state governments, public and private higher education institutions, independent school districts, for-profit organizations, public or Indian housing authorities, U.S. territories and possessions, faith-based and community-based organizations, regional organizations, and non-domestic (non-U.S.) entities and foreign components of U.S. organizations.
Research must fall within FDA Center for Tobacco Products' regulatory authority and address one or more high-priority topics: Addiction, Behavior, Communications, Health Effects, Product Composition and Design, or Toxicity. Applicants must address all components within their selected subtopic(s). Awards will be administered by NIH using funds made available through FDA Center for Tobacco Products under the Family Smoking Prevention and Tobacco Control Act (FSPTCA), Public Law 111-31.
The CFDA number is 93.077 (Family Smoking Prevention and Tobacco Control Act Regulatory Research). Scientific merit review encompasses significance, approach, innovation, principal investigator competency, resource adequacy, budget, period of support, and where applicable, measures protecting humans, animals, or the environment. Relevance to tobacco control regulatory research program priorities is considered in funding decisions. Applicants requesting $500 thousand or more in direct costs for any one year must contact the appropriate NIH Institute or Center no later than six weeks before the anticipated submission date. Renewal grants may only be submitted in response to a specific funding opportunity announcement. Award amounts and periods of support are determined based on project merit and grant mechanism.
Forecast synopsis
The Tobacco Regulatory Science Program, participating NIH Institutes and Centers (ICs), and the United States Food and Drug Administration (FDA) Center for Tobacco Products (CTP) intend to issue a Notice of Funding Opportunity (NOFO) soliciting applications for High-Priority Research Projects in Tobacco Regulatory Science (Clinical Trial Optional).
The FDA and NIH share an interest in supporting research that could inform FDA's tobacco regulatory authorities. High-priority research encouraged by this NOFO is expected to provide additional scientific data to the research base to inform the regulation of tobacco products to protect public health. Although a vast and sound science base exists related to the Family Smoking Prevention and Tobacco Control Act (FSPTCA), Public Law 111-31, the NOFO will seek high-priority research that will provide additional science for the FDA to consider as it implements the FSPTCA.
In order to be considered responsive, research must (1) be within the regulatory authority of FDA CTP, (2) address one or more of the following topics: Addiction, Behavior, Communications, Health Effects, Product Composition and Design, and/or Toxicity; and (3) address all components within the subtopic(s) of the selected topic(s).
Awards will be administered by NIH using funds made available through FDA CTP and the FSPTCA. TRSP is authorized to forecast this opportunity under The Public Health Service Act and the FSPTCA, Public Law 111-31, 42 US Code 300u-3.
Eligibility
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions). Non-domestic (non-U.S.) components of U.S. OrganizationsForeign components, as defined in the NIH Grants Policy Statement
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity